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Abstract
Objective: Coreceptor switch from CCR5 to CXCR4 is associated with HIV disease progression. The molecular and
evolutionary mechanisms underlying the CCR5 to CXCR4 switch are the focus of intense recent research. We studied the
HIV-1 tropism dynamics in relation to coreceptor usage, the nature of quasispecies from ultra deep sequencing (UDPS) data
and their phylogenetic relationships.
Methods: Here, we characterized C2-V3-C3 sequences of HIV obtained from 19 patients followed up for 54 to 114 months
using UDPS, with further genotyping and phylogenetic analysis for coreceptor usage. HIV quasispecies diversity and
variability as well as HIV plasma viral load were measured longitudinally and their relationship with the HIV coreceptor
usage was analyzed. The longitudinal UDPS data were submitted to phylogenetic analysis and sampling times and
coreceptor usage were mapped onto the trees obtained.
Results: Although a temporal viral genetic structuring was evident, the persistence of several viral lineages evolving
independently along the infection was statistically supported, indicating a complex scenario for the evolution of viral
quasispecies. HIV X4-using variants were present in most of our patients, exhibiting a dissimilar inter- and intra-patient
predominance as the component of quasispecies even on antiretroviral therapy. The viral populations from some of the
patients studied displayed evidences of the evolution of X4 variants through fitness valleys, whereas for other patients the
data favored a gradual mode of emergence.
Conclusions: CXCR4 usage can emerge independently, in multiple lineages, along the course of HIV infection. The mode of
emergence, i.e. gradual or through fitness valleys seems to depend on both virus and patient factors. Furthermore, our
analyses suggest that, besides becoming dominant after population-level switches, minor proportions of X4 viruses might
exist along the infection, perhaps even at early stages of it. The fate of these minor variants might depend on both viral and
host factors.
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Introduction
Human immunodeficiency virus type 1 (HIV-1) entry into host
cells requires synchronized interactions of the envelope glycopro-
tein gp120 with the CD4 receptor and with one of the chemokine
receptors, CCR5 or CXCR4. HIV-1 tropism for the chemokine
receptors CCR5 and CXCR4 has been shown to be associated
with disease progression [1]. Viruses, especially those using the
CCR5 receptor to enter the target cells (R5 viruses), are generally
predominant at early stages of HIV-1 infection, whereas the
emergence of CXCR4-using viruses (X4 viruses) generally occurs
at later stages [2]. Variation in R5 Env proteins can also influence
the ability of a virus to utilize various levels of CD4 and CCR5
found in different cell types, such as macrophages and T-cells. The
presence of X4 viruses is consistently associated with low CD4+ T-
cell counts and accelerated disease progression, although it is still
unclear whether it is the cause or consequence of disease
progression [3,4]. Inferring HIV-1 coreceptor usage from a
genotype is becoming more and more important for appropriately
treating long-term patients as the level of CXCR4-using viruses is
associated with risk of virological failure to maraviroc-containing
regimens in a dose-dependent fashion [5,6].
The primary genetic determinant for the HIV coreceptor usage
is the third variable region (V3) of the HIV gp120 envelope
glycoprotein encompassing approximately 35 residues (varying in
length depending on the viral isolate) with a conserved disulfide
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bridge at the base of the loop. The presence of basic residues at V3
reference positions 11 and 25 is strongly predictive of CXCR4
usage but there are exceptions to this rule. The evolution of
CXCR4 use following a host-specific mutational pathway could be
influenced by the immune pressure that promotes a rapid host-
specific adaptation. This scenario appears to limit the incidence of
the R5-to-X4 coreceptor switch.
The detection of HIV quasispecies at very low frequencies is
limited when standard bulk-nucleic acid sequencing methods are
used. The phenotypic assays to assess HIV tropism can reliably
detect minorities of less than 5% of the viral population but are
cost-intensive and time-consuming [7]. Taking into account the
plausible emergence of HIV minor variants during the follow-up,
our analysis involved the use of powerful technology of ultra-deep
pyrosequencing (UDPS) after PCR amplification of the env gene,
coding for the viral glycoprotein gp120, encompassing the
tropism-related V3 loop region.
The aim of the present study was to analyze the HIV-1 tropism
dynamics in relation to coreceptor usage, the nature of HIV-1
quasispecies and their phylogenetic relationships from a large
nucleotide sequence data generated by UDPS, prior and during
long term antiretroviral therapy.
The HIV tropism analysis of the vast amounts of sequence data
was automated by computer assistance using the geno2pheno 454
system [5]. It handles all processing and prediction steps involved
in the prediction of coreceptor usage from UDPS data. Such data
together with their known sampling dates were used to establish
phylogenetic relationships and to analyze the evolution model for
the dynamics of HIV coreceptor usage.
Materials and Methods
Patients
A total of 133 stored plasma samples obtained from nineteen
HAART (highly active antiretroviral therapy)-treated patients
were collected yearly for a 6 to 11-yr period of follow-up. No
patient received CCR5 antagonists. We selected HIV infected
adults with well known anti-viral therapy histories and schedule,
and a good adherence record. All patients were followed by a
minimum of 6 years and sampled at least four times during the
study. Their history of HIV infection was based on time from
seroconversion. Baseline for drug-naive individuals was considered
as the first time they were assessed at INBIRS, while it was the
time of the first sample available for those HAART-experienced
patients (Table 1).
CD4 T cell count and HIV-RNA plasma level (range of 50–
500,000 HIV-1 RNA copies/mL; VERSANT HIV-1 RNA
version 3.0 bDNA Assay, Siemens Diagnostics) were measured
at sample collection. The optimal virological response was defined
as having a viral load #50 copies/mL (#1.7 log) at each
measurement throughout the study. To detect HIV-1 viremia
below this threshold with an input plasma volume of 500 ml, a
centrifugation step prior to RNA extraction was added (23,5006g
at 4uC for 60 min (Mikro22R, Hettich, Germany) and the dilution
factors were decreased [8]. HIV genotypic tropism testing was
performed using the stored plasma samples.
The research project was submitted to the Fundación Huésped
Ethics Committee Review Board, Buenos Aires, on June 27th,
2012. It was approved on July 02, 2012. All participants recruited
in the present study had been included in a larger, previous
project. The latter involved clinical, virological and epidemiolog-
ical aspects of the HIV/HCV coinfection and all patients provided
an informed consent which was recorded during sample collection.
Taking into consideration that the present study is centered on
additional virological aspects of the HIV infection and that the
biological samples used were those previously collected, there was
no need for additional patient visits. Hence, the Fundación
Huésped Ethics Committee Review Board waived the need for a
new written informed consent from the participants for the present
study. The design of the present study (retrospective and
longitudinal) and the conditions detailed above were considered
at the moment of requesting the Ethics Committee for the
procedure approval.
RNA extraction, cDNA synthesis and V3-nested PCR
RNA extraction was performed using the Viral RNA mini kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. cDNA-synthesis was performed using 10 ml of
RNA, specific primer V3-r (59 GAGGGGAATTTTTC-
TACTGT, position 7572-7533 in HXB2), [9] and Superscript II
(Invitrogen) according to the manufacturer’s instructions in a total
volume of 20 ml.
Amplification of the V3 region was carried out using the specific
primers V3-r and the V3-f (59 CACAGTACAATGTACACATG,
position 6943–6962 in HXB2) for the first round of the PCR
followed by the nested reaction using the primers V3-nf (59
AAATGGCAGTCTAGCAGAAG, position 7006–7025 in
HXB2) and V3-nr (59 ACAATTTCTGGGTCCCCTCC, posi-
tion 7338–7319 in HXB2). The product size is 320 bp long. The
primers employed for the second round were modified by 59 Tag
extensions, which provided binding sites for the multiplex
identifiers (MIDs). The tags were as follows: sense-Tag 59-
CACGACGTTGTAAAACGA-39; antisense-Tag 59-CAGGAAA-
CAGCTATGACC-39. MIDs allowed for the identification of
samples after the pyrosequencing procedure was complete.
In order to ensure a good sampling as well as to optimize the
study of the genetic heterogeneity of viral population present in
0.75 ml of plasma by UDPS analysis, PCR amplicons from 3
reactions were pooled for each sample.
Ultra-deep pyrosequencing (UDPS)
Ultra deep pyrosequencing (UDPS) on the Roche/454 Life
Sciences ‘‘Genome Sequencer-FLX’’ (GS-FLX) is a sensitive
sequencing technique able to detect low-frequency subpopulations
of virus and to generate thousands of sequences from a given
sample [10,11].
After PCR amplification, PCR-purified amplicons were quan-
tified using Quant-iT PicoGreen (Invitrogen, Life Technologies,
MI, USA). In addition, an Agilent 2100 bioanalyzer (Agilent Life
Science, Santa Clara, California, USA) was used to verify the
quality and length of amplicons.
After quality controls, PCR amplicons were pooled in equimo-
lar concentrations; subsequently PCR amplicons were combined
at an appropriate ratio with DNA capture microbead. Emulsion
PCR was performed, and DNA and beads were washed, purified
and prepared for pyrosequencing according to the manufacturer’s
instructions. HIV-V3 sequence and flanking genomic regions
amplified on each bead were determined by pyrosequencing on
the GS-FLX [12]. The raw sequence output (‘reads’) generated by
Roche/454 GS-FLX platform was processed by a script that
sorted reads by region and trimmed the tags.
There is a growing realization of the potential bias that
sequencing errors can introduce in next generation sequencing
data [13]. Here, we filtered the data obtained based on sequence
length, quality of base calls, frame shifts and k-mer frequencies,
and compared UDPS data with Sanger sequences obtained from
molecular clones as described below.
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In phylogenetic analyses we prioritize the detection of minor
variants, which may represent intermediate genotypes, low
frequency variants, or transient links among the prevalent
haplotypes. The most prevalent sequencing errors in 454 data
correspond to spurious insertions and deletions in homopolymeric
sequence regions. These errors have minimal or no effect in
probabilistic phylogenetic analysis, due to the lack of a framework
for modeling nucleotide insertions/deletions together with nucle-
otide substitutions, and thus indels are either ignored or treated as
missing/unknown characters by most maximum likelihood and
Bayesian phylogenetic algorithms. Missing data are treated as any
of A, T, C or G and therefore cannot support any particular
phylogenetic hypothesis [14]. Therefore, the influence of indels in
phylogenetic analysis is negligible compared to the impact that
minor, real variants can have on character optimization and thus
on phylogenetic inference. Here, we did pay much attention to
large read length differences, as they can result in large stretches of
missing data in sequence alignments, and consequently in inflated
levels of uncertainty (e.g. large numbers of equally good character
optimizations, excessive numbers of floating taxa, misleading
bootstrap supports, etc.). Thus, we filtered out reads with lengths
,300 bases. Pyrosequencing data are neither free of erroneous
base calls, which present rates similar to Sanger sequencing ones
[15]. We discarded all sequences displaying no base calls above 10,
and for the remaining sequences, all base calls with qualities
bellow 10 were replaced by Ns. Then, we trimmed out low quality
read ends such that no sequence with more than 5% positions with
Ns were kept in the processed dataset. After that, a second length
filtering round was applied to the remaining reads. These
procedures were performed using ad-hoc R scripts [16]. The
sequences obtained were submitted to a first round of phylogenetic
analysis as described below (section Phylogenetic analysis), after
which ostensibly large terminal branches, which we attribute to
outlier, possibly erroneous and/or chimera reads, were removed
(Fig. S1).
Prior to the determination of viral tropism along the follow up
(see section ‘‘HIV tropism prediction from genotype’’), the data
were further filtered out by the presence of frame shifts, and low
frequency k-mers were corrected by the Kec program [17].
In addition to the in-silico filtering described above, the error
rate of pyrosequencing analyzer was assessed by comparing UDPS
data vs. data generated by molecular cloning (Table S1). Briefly,
for this goal we have selected two patients (Pat1 and Pat3) with the
corresponding 4 sampling times. From new aliquots of their
plasma samples, PCR amplicons from 3 independent reactions
were obtained and pooled following identical lab procedures as
described for UDPS. Such product was further cloned, and 14–20
clones were Sanger sequenced. For each viral haplotype the
nucleotide and amino acid sequence obtained by both strategies
were compared qualitatively (identical nucleotide and amino acid
sequences) and quantitatively (relative frequencies in the total
population). The results were statistically analyzed on their relative
frequencies and no significant differences were found, indicating
that no major quantitative biases were introduced by the
experimental or computational processing methods.
HIV tropism prediction from genotype
The prediction of HIV coreceptor usage was carried out by
genotypic methods taking into consideration the availability of
timesaving, reliable and widely available algorithms [18].
Reads that passed the quality controls described above were
input to Geno2pheno [coreceptor] application at www.genafor.
org. This is a bioinformatic tool for HIV coreceptor prediction
based on a genotype approach [19]. This algorithm was followed
for each HIV viraemic plasma sample characterized during the
follow-up. A false positive rate (FPR) of 10% was chosen for
detecting X4-variants. As recommended by the European
guidelines for HIV-1 tropism determination, the cut-off used in
all the analyses carried out in this study, was chosen since it has
been shown to be a good predictor in both multi-experienced and
drug-naı̈ve patients [20,21]. By re-analyzing the MOTIVATE and
A4001029 trials, tropism predictions using V3 genotyping were
shown to be comparable, based on single or triplicate testing using
a FPR of 10% [22,23].
HIV-1 tropism was also predicted by two alternative algorithms.
However, taking into account the magnitude of nucleotide
sequence data emerged from UDPS, such models were applied
only for those viral variants detected most frequently ($5%) at
each sampling time. For this goal both position-specific scoring
matrix (PSSM) matrices (PSSM X4/R5 or PSSM SI/NSI) based
on single V3 sequences under their original cut-off values [24], and
the very recently described (SAAC+BLAST) hybrid’ approach





Age (years) 43.5 (66.6) 45.3 (66.4)
Male/female 4/2 11/2
HIV time post-infection2 20.2 (65.7) 16.6 (64.9)
Time of follow-up (months) 73 (610) 79 (622)
HIV subtype (B / non-B) 0/6 4/9
Time on HAART (years) 7.2 (60.8) 11.6 (64.2)
HIV viral load (pre-HAART/intra-HAART)3 4.6660.61/,1.70 4.3061.45/4.2461.66
CD4 T cell count (pre-HAART/intra-HAART)4 262680/3576237 4606243/3246147
%X4 using variants at baseline5 2.2 [0.5256.9] 4.1 [0217.8]
1Mean (6standard deviation).
2HIV infection date calculated as mid-point between last negative and first positive samples are indicated as years.
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(named HIVcoPred) fixing a threshold of 0.5 [25] were carried
out.
Phylogenetic analysis
Sequence alignments were generated by the parallel version of
the MAFFT multiple sequence alignment program, with default op
and ep. Iterative refinement, and the weighted sum-of-pair scores
and consistency score obtained from local alignments [26] were
used for individual phylogenies, whereas the alignment of the
reads from all patients was performed with the PartTree algorithm
[27]. The datasets obtained were considerably large. Individual
datasets ranged from 161 sequences in patient 23 to 2549
sequences in patient 6, whereas the full dataset (i.e. the sequence
alignment containing the sequences from all the 19 patients) had
24335 entries. The inference of optimal trees from large datasets is
a problem that cannot be solved in polynomial time [28,29,30].
However, heuristic methods have been developed that allow
exploring tree spaces with reasonable intensities and in affordable
times [31,32,33]. Here, phylogenetic trees were inferred by the
FastTree 2 program [34]. This program combines minimum-
evolution subtree-pruning-regrafting (SPR) and maximum likeli-
hood nearest-neighbor interchange (NNI) tree searches. FastTree
searches were performed with default parameters, which scale
search intensity according to dataset sizes by using up to 4xlog2(N)
rounds of minimum-evolution NNI, 2 rounds of SPR moves and
up to 2xlog(N) rounds of maximum-likelihood NNIs, where N is
the number of unique sequences in the dataset. Branch supports
were calculated using the phylogenetic bootstrap. For these
analyses, 100 resampled datasets were generated with the Seqboot
component of the Phylip package v6.3 [35] and analyzed by
FastTree 2 and the CompareToBootstrap.pl module provided with the
FastTree distribution. Given the large size of some of the
phylogenetic trees obtained, Kec haplotypes [section Ultra-deep
pyrosequencing (UDPS)] were also submitted for phylogenetic
analysis to present a clearer evolutionary relationship of these
variants.
For hypothesis testing, the analyses were constrained by
allowing only trees congruent with each hypothesis and the trees
obtained were compared against the corresponding unconstrained
trees. To test for the persistence of viral lineages along the course
of infection, searches were constrained such that sequences
clustered according to sampling time. Additionally, the idea that
X4 tropism evolves by traversing across low fitness valleys was also
tested [36]. Should this hypothesis be correct, the occurrence of
stochastic tunneling processes must be expected resulting in X4
sequences clustered into monophyletic groups [37]. Thus, for
patient trees that displayed clades composed of X4 sequences
mixed with small amounts of R5 ones, tree searches were
constrained so that these R5 sequences were excluded from these
clades. Significance tests were performed using both the approx-
imately unbiased (AU) and o non-scaled bootstrap probability (NP)
tests of CONSEL [38].
HIV Quasispecies Heterogeneity Analysis based on V3
loop amino acid sequences
UDPS sequences resulting from the correction pipeline were
analyzed to assess intra-patient diversity and quasispecies com-
plexity dynamics during follow-up. To assess diversity, the mean
genetic distance of amino acid sequences was calculated by
PROTDIST using Jones-Taylor-Thornton matrix [http://caps.
ncbs.res.in/iws/protdist.html].
To study the frequency distribution of reads in a viral
population rather than the total number of reads, we computed
the Shannon entropy. It has been defined in terms of the
probabilities of the different sequences than can appear at a given
time-point. This measure was calculated as -g p(i) log2 p(i) where
p(i) is the relative frequency of each read i (i = 1,…n, where n is the
total number of groups of identical reads) [39]. This quantity
measures the amount of uncertainty in the distribution and was
used in a similar manner by Delwart et al. [40]. The resulting
number was normalized as a function of the number of clones
analyzed, thus allowing comparisons of complexity among
different isolates. The normalized entropy, Sn, was calculated as
Sn = S/log2N, where N is the total number of sequences analyzed.
Sn is 0 when there is a single read (i.e., n = 1, no diversity) and
reaches its maximum value when the reads observed are equally
frequent [i.e., p(i) = 1/n for all i]. We monitored the changes in the
distribution of reads in an individual via determining the entropy
and looked for changes in this value.
TSL Matrix Based Input Vectors
TSL is an online tool (http://www.twosamplelogo.org/cgi-bin/
tsl/tsl.cgi) which distinguishes the residue frequency between two
types of datasets, on each of the positions of the given sample
sequences. In addition to generating a graphical representation of
the two given datasets (Positive and Negative sample), it also
generates the output format as TXT (raw values) which is the
residues’ frequency difference in the two samples with significance
value (as shown by p-value). This table with position-specific
frequency value was used to generate the frequency score of
residues in CCR5 and CXCR4 sequences independently. Since
each V3 peptide was 35 amino acids long, an input vector of 35
dimensions was generated.
Statistical analysis
Baseline characteristics of the study population were recorded as
absolute numbers and percentages and means 6 SD for
qualitative and quantitative variables, respectively. Mann-Whitney
U testing was used for group comparison purposes. The
association among quantitative variables was tested using the
Spearman correlation coefficient. Statistical significance was
assumed for P values below 0.05. All statistical analyses were
performed using SPSS v15.0 (SPSS Inc., Chicago, IL, USA).
Results
Patient’s characteristics
The population was comprised of 15 males (44.865.6 years old)
and 4 females (42.468.1 years old). Laboratory parameters were
recorded longitudinally (Table S2). Thirteen patients (Pat1, 3, 5, 6,
7, 8, 9, 18, 24, 25, 26, 27, and 28) were drug-naive individuals who
initiated antiretroviral therapy and have been on regular follow-up
since then. The remaining six had a previous history of HAART
exposure. These HIV infected persons have attended the Instituto
de Inverstigaciones Biomédicas en Retrovirus y Sida (INBIRS)
from 2002. They could be differentiated based on HAART
response during the entire follow-up: (A) Subjects achieving
sustained optimal virological responses to HAART with undetect-
able HIV-1 RNA for a mean of 7.2 years (patients responding to
HAART; n = 6); and (B) Subjects exhibiting at least one episode of
detectable HIV-1 RNA (HAART-treatment failure; n = 13)
(Table 1).
Dynamics of HIV Tropism
PLOS ONE | www.plosone.org 4 July 2014 | Volume 9 | Issue 7 | e102857
Comparison between HIV viral load and CD4 T cell count
according to HAART response. Detection of Predicted X4
and R5-Using V3 Sequences by Ultra-Deep Sequencing
Of the 19 HIV infected patients involved in this longitudinal
study, 133 plasma samples were yearly collected. These individuals
were followed up for 76.4618.4 months.
Viruses from 15 out of 19 patients were identified as HIV-1 BF
intersubtype by analyzing the env nucleotide sequence using the
NCBI genotyping tool (http://www.ncbi.nlm.nih.gov/projects/
genotyping/formpage.cg0) while the remaining were ascribed to
HIV-1 B subtype (Pat13, Pat23, Pat24). An individual (Pat14)
showed viruses belonging to BF and B subtypes (see below). The
HIV genomic characterization was further confirmed by maxi-
mum-likelihood phylogenetic analysis of the sequences studied
here (Figure 1) together with HIV-1 subtype reference sequences
from the Los Alamos National Laboratory (http://www.hiv.lanl.
gov/content/index).
At baseline, among all 19 patients, the mean (6SD) HIV viral
load was 4.89 log copies/mL (61.38). The mean HIV viral load at
baseline among the six patients from group A (those showing
sustained optimal virological responses to HAART) was 4.66 log
copies/mL (60.61), and the mean CD4+ T cell count was 262
cell/mL (680).
Among the thirteen patients from group B (those failing to
HAART), the mean (6SD) plasma HIV viral load level and CD4
T cell count were 4.30 log HIV copies/mL (61.45) and 460 cells/
mL (6243), respectively when the HIV strains harbored a higher
predominance of R5 tropism (82.4%618.92). Once the antiret-
roviral therapy was initiated, and still exhibiting a sustained R5-
tropic virus predominance, such parameters did not vary
significantly (4.2461.66 log HIV copies/mL, and 324.66146.6
cells/mL, respectively). However, the HIV viral load (mean6SD)
measured under HAART among those patients harboring X4-
using variants appeared slightly lower (3.7261.87 log HIV copies/
mL; p = 0.07). At baseline, neither the CD4 T cell count nor the
HIV viral load levels showed any correlation with the prevalence
of HIV X4-using variants into the viral population (p.0.05 by
Spearman Test).
Before antiretroviral therapy initiation, the relative abundance
of X4 tropic strains (median [IQR]) between sustained optimal
virological responders to HAART -group A- and patients failing to
HAART –group B- showed no significant differences (2.2%[0.5–
56.9] vs. 4.1% [0–17.8]), respectively; p = 0.89). At baseline, the
HIV tropism prediction in patients from group A showed that 4
out of 6 individuals exhibited HIV isolates with R5 tropism
predominance (98.9% [97.8–100]). On the contrary, the remain-
ing two patients (Pat 1, and 27) were predicted to be
predominantly infected with X4-using variants (75.2% and
95.6%, respectively).
During the follow-up of the thirteen patients from group B, four
distinguishable dynamics of the HIV tropism were observed. First,
those HIV isolates harboring a sustained tropism either R5
predominance (Pat 3, 6, 7, 13, 15, 17, 18, 21, 24), or sustained X4
tropism (patient 23); second, those viral isolates that switched from
R5 to X4 tropism (Pat 14); third, HIV variants from an individual
(Pat 9) that firstly appeared as X4-using and switched to R5 during
the longitudinal study; and lastly, viral variants characterized from
an individual (Pat 25) that experienced R5-to-X4 switch followed
by a X4-to-R5 reversion. The coreceptor usage did not show any
significant correlation with the HIV viral load (p = 0.55) but it
should be taken cautiously because our patients were on HAART.
The agreement between geno2pheno (g2p) and HIVcoPred or,
the position-specific scoring matrix (PSSM) as bioinformatics tools
for genotypic interpretation of HIV-1 tropism showed an overall
92% of concordance between the first two since 3 out of 41 R5-
variants were classified as X4 by HIVcoPred, and 2 out of 17 X4-
using were R5 by HIVcoPred. The comparison between g2p and
PSSM exhibited a concordance of 82%. Such value included a
complete correlation among R5-using variants but the disagree-
ment was found in 11 out of 19 sequences with scores associated
with X4-usage that were interpreted as R5-tropic by PSSM.
Phylogenetic inferences and evolution of HIV R5 and X4-
using variants
Phylogenetic analysis allowed the recovery of strongly supported
monophyletic groups of sequences corresponding to each patient,
except for patients 14 and 24 (Figure 1). Sequences from each
sampling point and from temporally adjacent ones displayed a
tendency to cluster together in some of the patient clades (patients
3, 6, 7, 9, 13, 15, 20, 21, 24, 25 and 28; Figure 2; Figures S2-S17).
However, the majority of these clades displayed a clear
intermingling of sequences from different sampling times, indicat-
ing the existence of various viral lineages that persist along the
infection. Furthermore, in no case sequences from a determined
sampling point constituted a monophyletic group. Patient 14
presumably experienced a superinfection during the course of the
follow-up (Figure S2; see below). The lack of resolution for patient
24 sequences possibly obeys to its basal position at the clade
corresponding to subtype B sequences [41,42] (Figure S14).
Given that many nodes of the single patient clades showed very
low bootstrap supports, with an important proportion of tree
nodes unrecovered in the bootstrapped trees (Table 2), the
observed apparent complexity of viral populations was assessed
using constrained analyses that were compared to unconstrained
ones using approximately unbiased (AU) and non-scaled bootstrap
probability (NP) tests. All the constrained trees obtained presented
poor likelihoods as compared to the trees obtained in uncon-
strained searches, supporting the existence of several viral lineages
evolving independently along the infection (Figs. 2 and S18-;
Table 3).
Phylogenetic trees also indicated a complex scenario for the
emergence of X4 usage. Several individual patient topologies
showed that X4 variants can evolve in multiple, independent
events along the infection (Figure 2; Figures S1–S16). However,
some patient clades displayed subclades composed mostly of X4
sequences, supporting the hypothesis that the R5 to X4 transition
can, in some cases, imply a transition through a fitness valley,
where intermediate variants exhibited a reduced replication
capacity and were present at much lower frequency (Patients 1,
7, 9 and 25; Figs. 2 and S2–S18; Table 3). Thus, our results are
compatible with data published previously indicating that CXCR4
usage can emerge in multiple lineages, and that the occurrence of
fitness valleys depends on viral genetic background [36].
The dynamics of HIV evolution according to the coreceptor
usage appeared also to be host-related. Among those that were
analyzed longitudinally, the X4-using variants exhibited alterna-
tive behaviors after their emergence. Several subjects (3, 6, 7, 15,
17, 18, and 25) exhibited dispersed X4-variants that were
phylogenetically intermingled among R5-using ones. The vast
majority did not reach a substantial frequency in the viral
quasispecies population, hence allowing presuming a neutral
evolution or alternatively, the existence of negative selection
pressure. In contrast, other emerging X4-using variants did not go
extinction, suggesting the existence of positive selection processes
(Pat 3, 7, and 25; Figure 2) that conducted to the establishment of
X4-subclade. Some individuals showed particularly interesting
cases. For instance, the R5-to-X4 switch in subject 25 occurred at
thirty-one months from baseline but then, after nine months, a
Dynamics of HIV Tropism
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reversion to R5-using variants predominance was observed.
Remarkably, the R5-using variants that predominated at 40
months were closely related to sequences sampled at times 0 and 8
months, indicating that the reversion to R5 usage responded to the
rise of lineages that were already present at the beginning of the
follow-up (Fig. 2c; Fig. 3d). Patient 9 also verified a coreceptor
switch but it was from X4-to-R5 switch. In this host, two X4
haplotypes were indentified; one of them was present at the
beginning of the follow-up and could have become extinct after
the second sampling time. The R5 lineages present at 84 and 95
months of the follow-up emerged independently of this lineage
(Fig. S6; Fig. 3b). These observations reinforce the idea of the
Figure 1. Maximum likelihood phylogenetic tree of C2-V3-C3 nucleotide sequences from patients included in the study. Patient-
related clusters are identified in different colors as indicated at the bottom of the figure. The vertical size of the clusters is proportional to the number
of reads in the cluster and the horizontal size of the clusters shows their maximum genetic depth. Bootstrap values are given on branches. Branch
lengths are proportional to the number of nucleotide substitutions per aligned site (bar = 0.1 substitutions).
doi:10.1371/journal.pone.0102857.g001
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existence of complex lineage assemblages evolving along the HIV
infection.
Another case of R5-to-X4 switch was observed in subject 14
(Fig. S8; Fig. 3e). However, taking into account that the X4-
variants observed were both phylogenetically distant and tempo-
rally separated from the unique pre-existent R5-haplotype, such
apparent reversion in the HIV tropism could be probably
explained by two independent events of infection. At the fourth
and fifth sampling times, when the HIV viral load was fluctuating,
two X4-using haplotypes emerged and became highly predomi-
nant accompanied by R5-using variants not related with that
found previously at baseline.
Intrapatient dynamics of the HIV quasispecies evolution
and the coreceptor usage
Here, at least in a single sampling time during the follow-up,
many patients showed the coexistence of both R5 and X4-using
variants with dissimilar frequencies each. Under drug naı̈ve
conditions, among the 13 patients able to study prior to
antiretroviral therapy initiation, X4-using variants were detected
with an intra-patient prevalence ranging from 0% to 95.6%
(median [IQR]: 4.1% [2.1%–37.5%]). Similarly, the prevalence of
intra-patient X4- using variants among drug-experienced patients
ranged from 0% to 88.2% (4.1% [1.6%–27.0%].
The intra-host analysis of V3 amino acid sequence dynamics
showed that the alternative coreceptor R5 or X4 usage may imply
one (i.e. Pat 9) or several (i.e. Pat 7) amino acid replacements. The
intra-patient quasispecies diversity and variability (by Shannon
entropy) at a protein level ranged from 0.016 subs/site to 0.264
subs/site and from 0.21 to 0.62, respectively assessing different
selection pressures over time. Both parameters showed no
correlation with intra-host prevalence of X4-using variants (p.
0.05, by Spearman test). Likewise, no significant differences
(Mann-Whitney test p.0.05) were observed when comparing the
Figure 2. Twin maximum likelihood phylogenetic trees of C2-V3-C3 nucleotide sequences showing sampling time and tropism.
Three exemplary twin trees obtained from patient 3 (Figure 2a), 7 (Figure 2b), and 25 (Figure 2c). The other trees are shown as Supporting
Information. For each patient, the left tree depicts the distribution of viral variants according to the sampling time (blue: first, green: second, pink:
third, orange: fourth, gray: fifth); the right tree shows the relationships among viral variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is proportional to the number of reads in the cluster and the horizontal size of the clusters shows
their maximum genetic depth. Branch lengths are proportional to the number of nucleotide substitutions per aligned site (bar = 0.1 substitutions).
doi:10.1371/journal.pone.0102857.g002
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median [IQR] diversity and variability of amino acid sequences
between those sampling times showing X4 variants predominance
(0.032 [0.023–0.056] and 0.27 [0.24–0.38], respectively), against
those exhibiting R5 variants predominance (0.049 [0.030–0.091]
and 0.36 [0.29–0.42], respectively).
In this scenario, the next step of this study was to analyze
longitudinally at intra-tropism level, the dynamics of the HIV
quasispecies composition. Among our patients, two models were
observed (Figure 3; S18-S30). On the one hand, HIV haplotypes
from Pat 6, 13 and 15 showed null or, small variations in their
relative frequencies of R5 haplotypes during the study period
(75.8610.5 months), despite HIV replication fluctuations (Fig. 3a,
3d, 3e, S20, S23, S24). In contrast, other patients showed larger
variations in their HIV quasispecies composition during a similar
period of time (79.6623.2 months), depicting pronounced
fluctuations of haplotype frequencies (Pat 3, 7, 9, 14, 21, 24, 25)
(Figure 3, S19, S21, S22, S27, S28, S29).
As expected, this second group exhibited significant higher
values than the former on its quasispecies heterogeneity-related
parameters (diversity and variability) (p,0.001 and p,0.0016
respectively). Nevertheless, the period of time involved in the
follow-up was similar but considering that the interval between
sampling times was irregular, changes into quasispecies composi-
tion could not be advised properly and further research is
deserved.
Figure 3. Intra-patient relative abundance of R5 and X4-using variants identified over time. Longitudinal analysis of the relative
abundance (y left axis: percentage) of R5 (blue range) and X4 (red range) variants at different time points (x axis: sampling times in months). At the
first sampling time, the most abundant variant is identified by darker color and named as ‘‘R5.1’’ or ‘‘X4.1’’, accordingly. Colors become clearer
according to the decrease in their relative abundance. ‘‘R5.ot’’ and ‘‘X4.ot’’ include those viral variants with very low relative abundance. For
subsequent sampling times, the color palette is respected following the first one in order to allow correlating the longitudinal variation of the viral
variants first identified. HIV viral load are represented (y right axis; as log copies/ml). The V3 amino acid sequence (and between brackets, their
relative false positive rate by geno2pheno) of the most common variants in each patient is shown.
doi:10.1371/journal.pone.0102857.g003
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Sequence Analysis by Two Sample Logo (TSL)
The analysis of the relative frequencies of amino acids at a
position in the X4- and R5-tropic datasets aligned sequences
showed significant differences. It was found that positively charged
amino acids such as Lys (position 8) and Arg (positions 11, 13, 23,
24) and the large ones such as Ile (position 12) and Phe (position
20) are present at higher frequencies in the X4-tropic, while the
frequency of occurrence of Asn (position 5) and small amino acids
(Gly, Ala, Ser, Pro, etc.) was relatively higher in the R5-tropic
sequences (Figure 4).
Discussion
Human immunodeficiency virus type 1 (HIV-1) tropism for the
chemokine receptors CCR5 and CXCR4 was shown to be
associated with disease progression. HIV-R5 viruses are generally
predominant at early stages of HIV-1 infection, whereas the
emergence of X4-viruses generally occurs at later stages. However,
the evolution of virus tropism under HAART is controversial and
the selective mechanisms driving emergence of CXCR4-using
variants are still unrevealed [43,44].
In the present study we applied a phylogenetic framework to a
large dataset generated by ultra deep pyrosequencing (UDPS)
aimed at studying the population dynamics of HIV coreceptor
usage. To achieve this aim, a longitudinal follow-up was carried
out for up to 11 years of HIV infected patients most of whom were
HAART-naı̈ve at baseline while others were experienced ones.
In our study, in the majority (77%) of HAART-naive patients,
R5-using viruses were detected. Taking into account that X4 virus
is more likely to be detected in more advanced disease, its presence
at baseline could be explained considering that late diagnosis of
HIV infection occurs in a substantial proportion of patients newly
diagnosed as HIV-positive in Argentina [45] and other countries
[46]. The presence of both R5- and X4-tropism in naı̈ve and long
term treated patients at advanced stage of infection argues against
a role of HAART itself in the tropism switch. Instead, the infection
progress to later stages with eventual immunological impairment
might propitiate an increasing appearance of X4-tropic viruses. In
contrast with previous assumptions but in line with other reports
[47,48], we found that the median CD4 cell count was not
significantly associated with X4-coreceptor usage virus. This
inconsistency could be explained considering the plausible late
stage of infection among our patients allowing the R5 viruses
develop mutations that increase their cytophatic capacity on CD4
T cells.
After establishing inter- and intra-host phylogenetic relation-
ships among HIV-1 isolates characterized during this longitudinal
study, the persistence of several viral lineages evolving indepen-
dently along the infection was statistically supported, indicating a
complex scenario for the evolution of viral quasispecies. In
agreement with recent studies, some viral populations displayed
significant evidence of stochastic tunneling processes [36,37],
which supports the evolution of X4 variants through fitness valleys,
whereas viruses from other patients displayed no evidence of this
phenomenon. Considering that HIV, like other RNA viruses, can
evolve rapidly over short periods of time, the switch in the
coreceptor usage could also occur very rapidly as well. As a
consequence, the selection process on viral variants is difficult to
prove. However, the time needed to switch from R5- to X4 has
been estimated around 4 years post-infection [37]. Here, as it is
already known, HIV variants using either CXCR4 or CCR5 were
found to coexist in plasma.
Furthermore, our data showed that X4 usage can evolve in
multiple, independent events along the infection. The specific
mutational pathway that led to CXCR4-usage was different from
viruses found in each individual, and is likely to be at least partially
constrained by the viral background. The constraints on the R5 to
X4 mutational pathways and the low fitness of transitional
intermediate variants support that X4 variants were present at
extremely low frequencies in some patients, in agreement with the
results reported recently [49]. In this context, some individuals
exhibited X4-using viral variants that were able to overcome such
fitness valley and became predominant. Phylogenetically they
appeared as intra-host monophyletic groups or clades dominated
largely by X4 sequences. Alternatively, other X4-using variants
seem to belong to lineages that failed to overcome such fitness
valley and thus appeared intermingled with R5-variants along the
phylogenetic trees and were present at low frequencies only
detectable by using deep-sequencing techniques. Apparently, such
alternative pathways are not mutually exclusive, as the phylogenies
that displayed X4-clades also presented spare, interspersed X4
sequences that might correspond to evolutionary dead ends.
Interestingly, a reversion in the predominance from X4-to-R5
using variants was also observed. This reversion was coincident
Figure 4. Comparative frequency of amino acid residues between R5- and X4-viruses. By using the two sample logo (TSL) amino acid
residues with significant difference in the frequency between the two datasets (R5-tropic n = 41, lower panel; X4-tropic n = 19, upper panel) are
shown at the specific sites in the HIV gp-120 V3 sequences. Residues between the two panels denoted those with the equal frequency in two
datasets; when such frequency was approximately equal, positions showed no residues.
doi:10.1371/journal.pone.0102857.g004
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with a strong treatment-induced suppression of HIV viral load and
reduced T-cell turnover, as reported previously [50]. Hence, the
dynamics of HIV evolution of coreceptor usage appeared to
depend on the individual studied as well as the genotype of the
variant transmitted. In this sense, among those infected predom-
inantly with R5-tropic viruses we observed two dynamics on its
haplotypes composition. On the one hand, those showing little
variations during the longitudinal study suggesting that prolifer-
ation of latently infected cells could be the main mechanism
accounting for virus persistence. On the other hand, those
exhibiting more dramatic changes in their quasispecies could
reflect residual virus replication despite HAART [44].
The intra-host X4-predominance did not correlate with
parameters of quasispecies heterogeneity during this longitudinal
study. Instead, a positive correlation was reported by two cross-
sectional studies [21,51]. The different study design is a key
explanation to such discrepancy. Besides, neither the mutational
pathways toward X4-using variants necessarily implied heteroge-
neity accumulation, nor the X4-variants appeared intrinsically
more heterogeneous. When comparing the V3-loop amino acid
sequences, a unique discrepancy was observed among some
variants ascribed to R5 or X4-inferred tropism. But these changes
followed a pattern that revealed that positively charged and larger
amino acids are more frequent in X4- than in R5-tropic
sequences, as reported recently [25].
In our study, the HIV-1 tropism assessment did not include
phenotypic assays as gold standard. This limitation in conjunction
with both the unavailability of peripheral blood mononuclear cells
[52] and the predominance of HIV-1 BF intersubtype isolates [53]
may impair the X4-using variants detection. We used three
alternative methods for tropism determination based on the
genotypic prediction of HIV-1 coreceptor usage through bioinfor-
matics tools based on V3 loop viral sequences. Although we found
a good correlation between them, as reported previously [54], the
use of ultra-deep sequencing techniques restricted the tropism
analysis to the V3 loop without taking into consideration other
changes in the viral envelope that may influence coreceptor usage
and viral fitness. Particularly, substitutions in the V1, V2, C4
regions of gp120 and gp41 protein as well as differences in Env
glycosylation patterns are known to play an important role in the
determination of the coreceptor usage and may compensate loss-
of-fitness mutations in V3 [49,55,56,57,58,59,60].
In conclusion, the dynamics of HIV coreceptor usage showed
several viral lineages evolving independently along the infection
accompanied by a complex evolution of viral quasispecies. Several
HIV R5 and/or X4 haplotypes were characterized among the
patients studied, exhibiting a dissimilar inter- and intra-patient
predominance as a component of the viral population still on
antiretroviral therapy. Furthermore, our analyses suggest that,
besides becoming dominant after population-level switches, minor
proportions of X4 viruses might exist along the infection, perhaps
even at early stages of it. The fate of these minor variants might
depend on both viral and host factors.
Supporting Information
Figure S1 Phylogenetic trees before (A) and after (B)
removal of outlier sequences (indicated by red dia-
monds in panel A). The tree corresponds to patient 3
sequences. The numbers of outliers and the disposition of the
corresponding terminals were equivalent for the rest of patients
(not shown).
(TIF)
Figure S2 Twin trees obtained from patient 1. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S3 Twin trees obtained from patient 5. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S4 Twin trees obtained from patient 6. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S5 Twin trees obtained from patient 8. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S6 Twin trees obtained from patient 9. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S7 Twin trees obtained from patient 13. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
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horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S8 Twin trees obtained from patient 14. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S9 Twin trees obtained from patient 15. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S10 Twin trees obtained from patient 17. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S11 Twin trees obtained from patient 18. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S12 Twin trees obtained from patient 21. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S13 Twin trees obtained from patient 23. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S14 Twin trees obtained from patient 24. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S15 Twin trees obtained from patient 26. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S16 Twin trees obtained from patient 27. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S17 Twin trees obtained from patient 28. The left
tree depicts the distribution of viral variants according to the
sampling time (blue: first, green: second, pink: third, orange:
fourth, gray: fifth); the right tree shows relationships among viral
variants according to tropism (X4-using variants: red, R5-using
variants: light green). The vertical size of the clusters is
proportional to the number of reads in the cluster and the
horizontal size of the clusters shows their maximum genetic depth.
Branch lengths are proportional to the number of nucleotide
substitutions per aligned site (bar = 0.1 substitutions).
(TIF)
Figure S18 Phylogenetic analysis of Patient 1 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S19 Phylogenetic analysis of Patient 3 Kec
haplotypes. The trees in left and right panels are twin trees on
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which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S20 Phylogenetic analysis of Patient 6 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S21 Phylogenetic analysis of Patient 7 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S22 Phylogenetic analysis of Patient 9 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S23 Phylogenetic analysis of Patient 13 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S24 Phylogenetic analysis of Patient 15 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S25 Phylogenetic analysis of Patient 17 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S26 Phylogenetic analysis of Patient 20 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S27 Phylogenetic analysis of Patient 21 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S28 Phylogenetic analysis of Patient 24 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S29 Phylogenetic analysis of Patient 25 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Figure S30 Phylogenetic analysis of Patient 28 Kec
haplotypes. The trees in left and right panels are twin trees on
which isolation time and tropism, respectively, were mapped.
Color codes are as in Figure 2.
(TIF)
Table S1 UDPS results validation by a comparative
analysis using conventional cloning.
(PDF)
Table S2 Laboratory results obtained during the follow-
up (expressed as months):predicted HIV tropism (by
Geno2pheno); HIV plasma viral load (log copies/mL);
CD4 T-cell count (cell/mm3).
(PDF)
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